The effect of jejunoileal bypass on the pharmacokinetics of digoxin in man.
- 1 March 1977
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 55 (3), 537-541
- https://doi.org/10.1161/01.cir.55.3.537
Abstract
Seven subjects who underwent jejunoileal bypass surgery for massive obesity participated in a study to examine the relative bioavailability of digoxin before and one to two months after surgery. They were given a loading dose of 1 mg digoxin in divided oral doses followed by oral maintenance doses of 0.5 mg daily. There were no significant differences in the area under the serum concentration time curve, steady state serum levels or 24 hour steady state excretion of digoxin before and after surgery. We conclude that the bioavailability of digoxin from the Lanoxin tablets employed is not impaired in these patients, although urinary d-xylose and 24 hour fecal fat excretion indicated moderate to severe malabsorption after surgery.This publication has 15 references indexed in Scilit:
- Digoxin Absorption From Tablets and ElixirJAMA, 1974
- Digoxin Tablet Bioavailability: Single-Dose and Steady-State AssessmentAnnals of Internal Medicine, 1974
- Tritiated digoxin XXIIAmerican Journal Of Medicine, 1974
- Evaluation of Digoxin Bioavailability in Single-Dose StudiesNew England Journal of Medicine, 1973
- New Considerations in Use of Jejunoileal Bypass in Patients with Morbid ObesityAnnals of Surgery, 1973
- The Absorption of Orally Administered [12α-3H]Digoxin in ManClinical Science, 1972
- Changes in body composition after jejunoileal bypass in morbidly obese patientsThe American Journal of Surgery, 1972
- Absorption of Digoxin in Patients with Malabsorption SyndromesNew England Journal of Medicine, 1971